Author details

Full Name

Johann Soret

Affiliation

Institut de Genetique Moleculaire de Montpellier, CNRS

ORCID

Career Start Year

1985

Papers

H Index

Expertise

CM4AI Collaborator

Nevan J Krogan (CM4AI)

PMID	Paper Title	Journal Title	Published Year
34893560	Splicing efficiency of minor introns in a mouse model of SMA predominantly depends on their branchpoint sequence and can involve the contribution of major spliceosome components.	RNA	2022
31927482	Splicing Defects of the Profilin Gene Alter Actin Dynamics in an S. pombe SMN Mutant.	iScience	2020
28258160	A new <i>cis</i>-acting motif is required for the axonal SMN-dependent Anxa2 mRNA localization.	RNA	2017
24298023	Characterization and in vivo functional analysis of the Schizosaccharomyces pombe ICLN gene.	Mol Cell Biol	2014
23221635	Implication of the SMN complex in the biogenesis and steady state level of the signal recognition particle.	Nucleic Acids Res	2013
24152552	Genome-wide identification of mRNAs associated with the protein SMN whose depletion decreases their axonal localization.	RNA	2013
21098506	Impaired minor tri-snRNP assembly generates differential splicing defects of U12-type introns in lymphoblasts derived from a type I SMA patient.	Hum Mol Genet	2011
20400941	Specific splicing defects in S. pombe carrying a degron allele of the Survival of Motor Neuron gene.	EMBO J	2010
18039666	Characterization of a short isoform of human Tgs1 hypermethylase associating with small nucleolar ribonucleoprotein core proteins and produced by limited proteolytic processing.	J Biol Chem	2008
18561205	A large fraction of unclassified variants of the mismatch repair genes MLH1 and MSH2 is associated with splicing defects.	Hum Mutat	2008
17283056	The SR family proteins B52 and dASF/SF2 modulate development of the Drosophila visual system by regulating specific RNA targets.	Mol Cell Biol	2007
17327915	Eye development under the control of SRp55/B52-mediated alternative splicing of eyeless.	PLoS One	2007
17076265	SR proteins as potential targets for therapy.	Prog Mol Subcell Biol	2006
15798212	The SR protein SC35 is responsible for aberrant splicing of the E1alpha pyruvate dehydrogenase mRNA in a case of mental retardation with lactic acidosis.	Mol Cell Biol	2005
15939885	Selective modification of alternative splicing by indole derivatives that target serine-arginine-rich protein splicing factors.	Proc Natl Acad Sci U S A	2005
15625279	Selective inhibition of topoisomerase I and various steps of spliceosome assembly by diospyrin derivatives.	Mol Pharmacol	2005
14757846	Topoisomerase I and II inhibitors control caspase-2 pre-messenger RNA splicing in human cells.	Mol Cancer Res	2004
15331664	A key role for stress-induced satellite III transcripts in the relocalization of splicing factors into nuclear stress granules.	J Cell Sci	2004
12494764	Phosphorylation-dependent control of the pre-mRNA splicing machinery.	Prog Mol Subcell Biol	2003
14678976	Altered serine/arginine-rich protein phosphorylation and exonic enhancer-dependent splicing in Mammalian cells lacking topoisomerase I.	Cancer Res	2003
11158320	Distinctive features of Drosophila alternative splicing factor RS domain: implication for specific phosphorylation, shuttling, and splicing activation.	Mol Cell Biol	2001
11285241	SC35 autoregulates its expression by promoting splicing events that destabilize its mRNAs.	EMBO J	2001
11559564	Specific inhibition of serine- and arginine-rich splicing factors phosphorylation, spliceosome assembly, and splicing by the antitumor drug NB-506.	Cancer Res	2001
9671500	Characterization of SRp46, a novel human SR splicing factor encoded by a PR264/SC35 retropseudogene.	Mol Cell Biol	1998
9358160	Characterization of multiple alternative RNAs resulting from antisense transcription of the PR264/SC35 splicing factor gene.	Nucleic Acids Res	1997
1465383	The PR264/c-myb connection: expression of a splicing factor modulated by a nuclear protooncogene.	Proc Natl Acad Sci U S A	1992
1557353	A potential splicing factor is encoded by the opposite strand of the trans-spliced c-myb exon.	Proc Natl Acad Sci U S A	1992
1549366	Transforming potential of truncated v-myb and stimulation of replication by gag-myb fusion products.	Oncogene	1992
1782565	A novel type of RNA-binding protein is potentially encoded by the opposite strand of the trans-spliced c-myb coding exon.	C R Acad Sci III	1991
1840680	C-myb proto-oncogene: evidence for intermolecular recombination of coding sequences.	Oncogene	1991
2185952	Chromosomal reallocation of the chicken c-myb locus and organization of 3'-proximal coding exons.	FEBS Lett	1990
2564440	Induction of nephroblastoma by myeloblastosis-associated virus type 1: state of proviral DNAs in tumor cells.	J Virol	1989
2452755	Organization of 5'-proximal c-myb exons in chicken DNA. Implications for c-myb tissue-specific transcription.	FEBS Lett	1988
3029704	myb-specific probes.	Nucleic Acids Res	1987
3032682	Expression of a truncated v-myb product in transformed chicken embryo fibroblasts.	FEBS Lett	1987
2427128	Transforming potential of the v-myb oncogene from avian myeloblastosis virus: alterations in the oncogene product may reveal a new target specificity.	Biochimie	1986
3006338	A cryptic transcription promoter in the myb oncogene of avian myeloblastosis virus.	Virology	1986
2989555	Transformation of Brown Leghorn chicken embryo fibroblasts by avian myeloblastosis virus proviral DNA.	J Virol	1985

1 - 38 of 38

Pedro A F Galante

Hospital Sirio Libanes

Career Start Year 2003

Number of shared co-authors 0

Qun Pan

University of Toronto

Career Start Year 2000

Number of shared co-authors 1

Robert K Bradley

Fred Hutchinson Cancer Research Center, University of Washington

Career Start Year 1998

Number of shared co-authors 0

Krishna M Sinha

The University of Texas MD Anderson Cancer Center

Career Start Year 1998

Number of shared co-authors 0

Marco Blanchette

Stowers Institute for Medical Research

Career Start Year 1997

Number of shared co-authors 0

Ping Liang

College of Chemistry and Chemical Engineering, Hunan University

Career Start Year 1995

Number of shared co-authors 1

Ryutaro Fukumura

SRL & Shizuoka Cancer Center Collaborative Laboratories Inc

Career Start Year 1995

Number of shared co-authors 0

Hans-Rudolf Hotz

Friedrich Miescher Institute for Biomedical Research

Career Start Year 1994

Number of shared co-authors 0

Anabella Srebrow

Universidad de Buenos Aires

Career Start Year 1993

Number of shared co-authors 1

Sandro J de Souza

Universidade Federal do Rio Grande do Norte

Career Start Year 1992

Number of shared co-authors 0

Ke Zhang

College of Life Science, Zhejiang University

Career Start Year 1989

Number of shared co-authors 1

Benjamin J Blencowe

University of Toronto

Career Start Year 1989

Number of shared co-authors 1

Yasushi Okazaki

Intractable Disease Research Center, Graduate School of Medicine, Juntendo University

Career Start Year 1989

Number of shared co-authors 0

Dieter Weichenhan

German Cancer Research Center (DKFZ)

Career Start Year 1988

Number of shared co-authors 0

Timothy C Burn

Incyte Research Institute

Career Start Year 1987

Number of shared co-authors 0

Harukazu Suzuki

RIKEN Center for Integrative Medical Sciences

Career Start Year 1985

Number of shared co-authors 0

Benoit Chabot

Agriculture and Agri-Food Canada

Career Start Year 1985

Number of shared co-authors 0

Karla M Neugebauer

Yale University

Career Start Year 1985

Number of shared co-authors 0

Marian J A Groot Koerkamp

Princess Maxima Center for Pediatric Oncology Research

Career Start Year 1983

Number of shared co-authors 1

Yoshihide Hayashizaki

Center for Integrative Medical Sciences

Career Start Year 1983

Number of shared co-authors 0

Angus I Lamond

University of Dundee

Career Start Year 1982

Number of shared co-authors 0

Robert M Stephens

Frederick National Laboratory for Cancer Research, Inc.

Career Start Year 1980

Number of shared co-authors 0

Stephen M Mount

University of Maryland, College Park

Career Start Year 1980

Number of shared co-authors 0

Dirk Eick

Helmholtz Center Munich and Center for Integrated Protein Science Munich (CIPSM)

Career Start Year 1980

Number of shared co-authors 1

Donald C Rio

University of California berkeley

Career Start Year 1979

Number of shared co-authors 0

Eric D Wieben

Mayo Clinic Rochester

Career Start Year 1979

Number of shared co-authors 0

Barbara J Wold

Merkin Institute for Translational Research, California Institute of Technology

Career Start Year 1976

Number of shared co-authors 0

Tom Maniatis

College des medecins du Quebec

Career Start Year 1968

Number of shared co-authors 1

Glauco P Tocchini-Valentini

Monterotondo Mouse Clinic (MMC), Italian National Research Council (CNR)

Career Start Year 1961

Number of shared co-authors 0

John S Mattick

Australia UNSW RNA Institute

Career Start Year 1951

Number of shared co-authors 0

row(s) 1 - 30 of 30

R??my Bordonn??

Institut de Genetique Moleculaire de Montpellier, CNRS

Co-authored papers 9

Florence Rage

University of Montpellier, CNRS

Co-authored papers 4

Rebecca Cacciottolo

University of Malta

Co-authored papers 1

Nevan J Krogan (CM4AI)

University of California San Francisco

Co-authored papers 1

Christine Guthrie

University of California san francisco

Co-authored papers 1

Yannick Gachet

Universite de Toulouse, CNRS

Co-authored papers 1

Yves Pommier

Center for Cancer Research, National Cancer Institute

Co-authored papers 1

St??phanie Solier

Gustave Roussy Cancer Center, INSERM U1170

Co-authored papers 1

Kelly E Nissen

University of California san francisco

Co-authored papers 1

Martine Antoine

Erasme University Hospital, Universite Libre de Bruxelles

Co-authored papers 1

Ruben J Cauchi

University of Malta

Co-authored papers 1

Pauline Duc

University of Montpellier, CNRS

Co-authored papers 1

Sylviane Olschwang

Aix Marseille Universite, INSERM GMGF UMR 1

Co-authored papers 1

Kristin L Patrick

Texas A&M University School of Medicine

Co-authored papers 1

1 - 14

Author Details

Column Actions

Recommended Authors

Collaborators